Global Contrast Enhanced Ultrasound Market by Type (Non-targeted, Targeted), by End-use (Clinics, Hospitals), by Product (Equipment, Contrast Agents) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global contrast enhanced ultrasound market was valued at USD1.8 billion in 2020. It is expected to grow at 4.0% compound annual growth rate (CAGR), between 2021 and 2028. The market growth can be attributed to the introduction of inexpensive contrast agents, an increase in ultrasound procedural volume, as well as the incorporation of contrast imaging modes into ultrasound systems. Contrast enhanced ultrasound (CEUS), which is less expensive, more radiation-free and more patient-friendly, is also superior to other technologies. Market growth is expected to be accelerated by this technology. In the fight against COVID-19, it is crucial to integrate CEUS technology into Point-of-Care (PoC), diagnostics.
This has led to a growing use of contrast-enhanced ultrasonography, which is able to detect COVID-19-related pneumonia early. The demand for this procedure has grown rapidly due to an increase in lung ultrasonography procedures. This will likely increase as more people develop cardiovascular and gastrointestinal disease.
The most preferred method for assessing lung disease in COVID-19 patients was contrast enhanced ultrasound. These devices also served as a bedside imaging tool that measured perfusion impairment in the brain, kidney and lung of COVID-19 children. CEUS can detect lung damage even in the symptomatic phase COVID-19. There are many studies that have been done to evaluate the effectiveness of CEUS in detecting microthrombi in COVID-19 sufferers. These studies will likely increase the use of CEUS in the future.
Due to increasing patient referrals for CEUS, frequent monitoring of Left Ventricular Volume and Ejection Fraction is essential in determining the type and timing of treatment that will be offered to patients with Cardiovascular Disorders. The poor endocardial border definition means that patients' LV and/or LVEF values are often underestimated, despite the availability of ultrasound imaging techniques such as harmonic imaging. The market is expected to grow because of the growing demand for accurate and sensitive diagnostic tools that can quantitatively assess the ventricular volume in patients with cardiac disease.
As these areas are the most important for clinical application of contrast-enhanced ultrasonic systems, it is expected that there will be an increase in CVDs, liver and kidney diseases, gastrointestinal disorders, and other vascular diseases. According to WHO, CVDs are the leading cause for death worldwide. CVDs are responsible for the deaths of 17.9 million people each year. With an increasing prevalence of CVDs, including alcohol and tobacco, sedentary lifestyles, and poor diets, the incidence of CVDs is on the rise.
Product Insights
With a market share of 72.6%, the equipment segment was the dominant product segment in 2020. Market growth has been fueled by the introduction of advanced ultrasound units that include transducer technology and other nonlinear imaging techniques. To increase product usability and enhance diagnostic experience, manufacturers of ultrasound scanners are more likely to offer comprehensive ultrasound imaging solutions in one system.
The new technology of contrast-enhanced ultrasound is being used in all future ultrasound technologies. Mindray, for instance, launched the DC-90 ultrasound system in December 2019 with an integrated contrast-enhanced mode. In the future, segment growth will be fueled by increased investment from drug companies, universities, and ultrasound manufacturers in developing contrast imaging-specific ultrasound modes & agents.
Type Insights
With a revenue share exceeding 73%, the non-targeted segment of the CEUS market dominated in 2020. This is the most popular CEUS imaging technique. All approved ultrasound contrast agents can be used in non-targeted applications. They are used to increase diagnostic sensitivity, determine blood volume and flow, and distinguish between benign and malignant liver tumors. Because of their popularity, the majority of commercially available products were non-targeted contrast agent.
These devices are used to measure the perfusion of organs and assess vascularity in target lesions (liver/kidney). Market growth is expected to be driven by the increasing prevalence of chronic diseases such as cancer and liver cirrhosis. The 2019 National Survey on Drug Use and Health (NSDUH) revealed that 14.1 million Americans had an alcohol-related disorder. Excessive alcohol consumption is one of the main causes of liver damage. It is expected that the changing global population of alcohol drinkers will positively impact the demand for services in ultrasound contrast imaging.
End-use Insights
Hospitals dominated the market, accounting for more than 58% of the total revenue in 2020. There is a rising demand for CEUS in hospitals due to increasing emergency visits. Hospitals have the highest revenue share due to their large patient base and high-quality ultrasound equipment.
Contraindications to the use of contrast agents include: Contraindications include intra-arterial injections of contrast agents, which can cause serious complications for patients. The segment is expected to grow because of the increased availability of specialists in hospitals and technicians who are skilled in the handling of equipment and contrast agents.
Regional Insights
North America held the largest market share, with over 24% in 2020. Although CEUS imaging has been used for cardiac and abdominal imaging in North America over the years, its approval for diagnosis of liver lesions is drawing more attention. The market is expected to grow due to several training and education programs for radiologists and sonologists on the diagnostic and therapeutic uses of CEUS in this region.
The U.S. has established medical codes, payment procedures, and coverage policies for the provision of ultrasound services in hospitals, clinics, and ambulatory centers. Additionally, general practitioners and family doctors are eligible for reimbursements for the use of ultrasounds at their offices. This has led to an increase in the number ultrasound procedures in the U.S. The country is likely to see a rise in the incidence of CVDs, IBDs, and other conditions that can cause inflammation.
The fastest CAGR is expected to be in Asia Pacific over the forecast period due to rising healthcare spending, particularly in China and India. The lack of organized reimbursement policies and the price-sensitive population in emerging economies are expected to increase the demand for affordable procedures such as contrast-enhanced ultrasonography imaging. The market is expected to grow due to the increasing number of government initiatives to improve the healthcare infrastructure in the region.
Market Share Insights & Key Companies
To increase their market share, the key players are pursuing various business strategies such as product launches, mergers and acquisitions, joint ventures, partnerships, and joint ventures. Daiichi Sankyo and GE Healthcare negotiated an agreement in March 2020. In this agreement, Daiichi Sankyo will transfer Japan's marketing authorization rights to GE Healthcare Pharma and return Japan's exclusive marketing & developmental rights for four diagnostic imaging agents. The following are some of the most prominent players in contrast enhanced ultrasound markets:
-
Lantheus Medical Imaging, Inc.
-
General Electric
-
Bracco Diagnostic
-
Siemens Healthcare GmbH
-
nanoPET Pharma GmbH
-
ESAOTE SPA
-
Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
Up Market Research published a new report titled “Contrast Enhanced Ultrasound Market research report which is segmented by Type (Non-targeted, Targeted), by End-use (Clinics, Hospitals), by Product (Equipment, Contrast Agents), By Players/Companies Lantheus Medical Imaging Inc, nanoPET Pharma GmbH, Siemens Healthcare GmbH, General Electric, ESAOTE SPA, Bracco Diagnostic, Shenzhen Mindray Bio-Medical Electronics Co Ltd”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Contrast Enhanced Ultrasound Market Research Report |
By Type | Non-targeted, Targeted |
By End-use | Clinics, Hospitals |
By Product | Equipment, Contrast Agents |
By Companies | Lantheus Medical Imaging Inc, nanoPET Pharma GmbH, Siemens Healthcare GmbH, General Electric, ESAOTE SPA, Bracco Diagnostic, Shenzhen Mindray Bio-Medical Electronics Co Ltd |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 241 |
Number of Tables & Figures | 169 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Contrast Enhanced Ultrasound Market Report Segments:
The market is segmented by Type (Non-targeted, Targeted), by End-use (Clinics, Hospitals), by Product (Equipment, Contrast Agents).
Contrast Enhanced Ultrasound Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Contrast Enhanced Ultrasound Market
Overview of the regional outlook of the Contrast Enhanced Ultrasound Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Contrast Enhanced Ultrasound Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Contrast Enhanced Ultrasound Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Non-targeted
2. Targeted
7. By End-use:1. Clinics
2. Hospitals
8. By Product:1. Equipment
2. Contrast Agents
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Contrast Enhanced Ultrasound Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Contrast Enhanced Ultrasound Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contrast Enhanced Ultrasound Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Contrast Enhanced Ultrasound Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Contrast Enhanced Ultrasound Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Contrast Enhanced Ultrasound Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Contrast Enhanced Ultrasound Market Size & Forecast, 2018-2028
4.5.1 Contrast Enhanced Ultrasound Market Size and Y-o-Y Growth
4.5.2 Contrast Enhanced Ultrasound Market Absolute $ Opportunity
Chapter 5 Global Contrast Enhanced Ultrasound Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Contrast Enhanced Ultrasound Market Size Forecast by Type
5.2.1 Non-targeted
5.2.2 Targeted
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Contrast Enhanced Ultrasound Market Analysis and Forecast by End-use
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End-use
6.1.2 Basis Point Share (BPS) Analysis by End-use
6.1.3 Absolute $ Opportunity Assessment by End-use
6.2 Contrast Enhanced Ultrasound Market Size Forecast by End-use
6.2.1 Clinics
6.2.2 Hospitals
6.3 Market Attractiveness Analysis by End-use
Chapter 7 Global Contrast Enhanced Ultrasound Market Analysis and Forecast by Product
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Product
7.1.2 Basis Point Share (BPS) Analysis by Product
7.1.3 Absolute $ Opportunity Assessment by Product
7.2 Contrast Enhanced Ultrasound Market Size Forecast by Product
7.2.1 Equipment
7.2.2 Contrast Agents
7.3 Market Attractiveness Analysis by Product
Chapter 8 Global Contrast Enhanced Ultrasound Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Contrast Enhanced Ultrasound Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Contrast Enhanced Ultrasound Analysis and Forecast
10.1 Introduction
10.2 North America Contrast Enhanced Ultrasound Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Contrast Enhanced Ultrasound Market Size Forecast by Type
10.6.1 Non-targeted
10.6.2 Targeted
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 North America Contrast Enhanced Ultrasound Market Size Forecast by End-use
10.10.1 Clinics
10.10.2 Hospitals
10.11 Basis Point Share (BPS) Analysis by End-use
10.12 Absolute $ Opportunity Assessment by End-use
10.13 Market Attractiveness Analysis by End-use
10.14 North America Contrast Enhanced Ultrasound Market Size Forecast by Product
10.14.1 Equipment
10.14.2 Contrast Agents
10.15 Basis Point Share (BPS) Analysis by Product
10.16 Absolute $ Opportunity Assessment by Product
10.17 Market Attractiveness Analysis by Product
Chapter 11 Europe Contrast Enhanced Ultrasound Analysis and Forecast
11.1 Introduction
11.2 Europe Contrast Enhanced Ultrasound Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Contrast Enhanced Ultrasound Market Size Forecast by Type
11.6.1 Non-targeted
11.6.2 Targeted
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Europe Contrast Enhanced Ultrasound Market Size Forecast by End-use
11.10.1 Clinics
11.10.2 Hospitals
11.11 Basis Point Share (BPS) Analysis by End-use
11.12 Absolute $ Opportunity Assessment by End-use
11.13 Market Attractiveness Analysis by End-use
11.14 Europe Contrast Enhanced Ultrasound Market Size Forecast by Product
11.14.1 Equipment
11.14.2 Contrast Agents
11.15 Basis Point Share (BPS) Analysis by Product
11.16 Absolute $ Opportunity Assessment by Product
11.17 Market Attractiveness Analysis by Product
Chapter 12 Asia Pacific Contrast Enhanced Ultrasound Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Contrast Enhanced Ultrasound Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Contrast Enhanced Ultrasound Market Size Forecast by Type
12.6.1 Non-targeted
12.6.2 Targeted
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Asia Pacific Contrast Enhanced Ultrasound Market Size Forecast by End-use
12.10.1 Clinics
12.10.2 Hospitals
12.11 Basis Point Share (BPS) Analysis by End-use
12.12 Absolute $ Opportunity Assessment by End-use
12.13 Market Attractiveness Analysis by End-use
12.14 Asia Pacific Contrast Enhanced Ultrasound Market Size Forecast by Product
12.14.1 Equipment
12.14.2 Contrast Agents
12.15 Basis Point Share (BPS) Analysis by Product
12.16 Absolute $ Opportunity Assessment by Product
12.17 Market Attractiveness Analysis by Product
Chapter 13 Latin America Contrast Enhanced Ultrasound Analysis and Forecast
13.1 Introduction
13.2 Latin America Contrast Enhanced Ultrasound Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Contrast Enhanced Ultrasound Market Size Forecast by Type
13.6.1 Non-targeted
13.6.2 Targeted
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Latin America Contrast Enhanced Ultrasound Market Size Forecast by End-use
13.10.1 Clinics
13.10.2 Hospitals
13.11 Basis Point Share (BPS) Analysis by End-use
13.12 Absolute $ Opportunity Assessment by End-use
13.13 Market Attractiveness Analysis by End-use
13.14 Latin America Contrast Enhanced Ultrasound Market Size Forecast by Product
13.14.1 Equipment
13.14.2 Contrast Agents
13.15 Basis Point Share (BPS) Analysis by Product
13.16 Absolute $ Opportunity Assessment by Product
13.17 Market Attractiveness Analysis by Product
Chapter 14 Middle East & Africa (MEA) Contrast Enhanced Ultrasound Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Contrast Enhanced Ultrasound Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Contrast Enhanced Ultrasound Market Size Forecast by Type
14.6.1 Non-targeted
14.6.2 Targeted
14.7 Basis Point Share (BPS) Analysis by Type
14.8 Absolute $ Opportunity Assessment by Type
14.9 Market Attractiveness Analysis by Type
14.10 Middle East & Africa (MEA) Contrast Enhanced Ultrasound Market Size Forecast by End-use
14.10.1 Clinics
14.10.2 Hospitals
14.11 Basis Point Share (BPS) Analysis by End-use
14.12 Absolute $ Opportunity Assessment by End-use
14.13 Market Attractiveness Analysis by End-use
14.14 Middle East & Africa (MEA) Contrast Enhanced Ultrasound Market Size Forecast by Product
14.14.1 Equipment
14.14.2 Contrast Agents
14.15 Basis Point Share (BPS) Analysis by Product
14.16 Absolute $ Opportunity Assessment by Product
14.17 Market Attractiveness Analysis by Product
Chapter 15 Competition Landscape
15.1 Contrast Enhanced Ultrasound Market: Competitive Dashboard
15.2 Global Contrast Enhanced Ultrasound Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Lantheus Medical Imaging Inc
15.3.2 nanoPET Pharma GmbH
15.3.3 Siemens Healthcare GmbH
15.3.4 General Electric
15.3.5 ESAOTE SPA
15.3.6 Bracco Diagnostic
15.3.7 Shenzhen Mindray Bio-Medical Electronics Co Ltd